Clinical experience with sorbinil--an aldose reductase inhibitor

Area of Science:

• Biochemistry
• Pharmacology
• Diabetology

Background:

• Animal studies suggest the polyol pathway is key to diabetic complications.
• Clinical trials are validating these findings in humans.

Purpose of the Study:

• To verify if polyol pathway inhibition is effective in treating diabetic complications.
• To assess the safety and efficacy of sorbinil in human subjects.

Main Methods:

• Clinical trials involving human subjects.
• Biochemical and electrophysiological assessments.
• Long-term safety data collection.

Main Results:

• Clinical data confirm biochemical and electrophysiological effects of polyol pathway modulation.
• Sorbinil demonstrated encouraging effects in diabetic neuropathy and retinopathy.
• Long-term use showed no significant adverse effects, except for rare hypersensitivity reactions.

Conclusions:

• The polyol pathway hypothesis is supported by clinical data.
• Sorbinil shows potential as a treatment for diabetic complications.
• Sorbinil has an acceptable safety profile for long-term use.